Case Study: New York Health System reduces drug diversion discrepancies with Imprivata Drug Diversion Intelligence

New York Health System reduces unresolved discrepancies to below 5% with Imprivata

A New York health system with 600 beds faced the challenge of preventing drug diversion, a serious issue impacting patient safety and compliance. Their manual approach was insufficient, and they lacked strong reporting capabilities and a means to instill best practices. They selected Imprivata and implemented its Drug Diversion Intelligence solution to automate detection and gain greater visibility.

The Imprivata solution provided behavioral analytics and AI modeling to detect and remediate drug diversion. This resulted in a significant reduction in unresolved discrepancies, bringing the monthly rate below 5%. The health system also gained a best-in-class dashboard for compliance and used the solution's reporting to educate frontline staff, leading to improved procedures and a measurable positive impact on care quality.